{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:00:29Z","timestamp":1780621229614,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Aberrant alternative splicing (AS) in cancer generates oncogenic proteomic diversity that drives tumor progression. Given the suboptimal efficacy of immune checkpoint inhibitors (ICIs) in gastric cancer (GC), the therapeutic potential of modulating RNA splicing to augment immunotherapy remains unclear. Here, we demonstrate that the splicing factor SRSF10 is progressively upregulated during gastric tumorigenesis and exhibits elevated expression in ICIs-resistant GC. Utilizing multiple mouse models, we confirmed that SRSF10 ablation with a selective inhibitor 1C8 robustly inhibits GC growth and enhances CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell infiltration via CCL2-mediated reprogramming of tumor-associated macrophages (TAMs). Notably, SRSF10 blockade restricts pre-neoplastic metaplastic cells re-entry the cell cycle and the TAMs reprogramming. Mechanistically, cell-autonomous SRSF10 activates mTOR signaling primarily through inclusion of exon 2 in the BCAA transaminase 2 (BCAT2) mRNA. Pharmacological antagonism of SRSF10 potentiated the therapeutic effect of anti-PD-1 antibody in\n                    <jats:italic>Tff1-CreER<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>T2<\/jats:italic>\n                    <\/jats:sup>\n                    <jats:italic>; Apc<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>fl\/fl<\/jats:italic>\n                    <\/jats:sup>\n                    <jats:italic>; p53<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>fl\/fl<\/jats:italic>\n                    <\/jats:sup>\n                    orthotopic GC models. Collectively, our findings revealed that SRSF10 orchestrates mTOR-CCL2 signaling by alternative RNA splicing of BCAT2 to reprogram TAMs, proposing SRSF10 as a tempting therapeutic target for GC immunotherapy.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08622-3","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:14:34Z","timestamp":1776878074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disrupting SRSF10-dependent BCAT2 exon skipping reprograms tumor-associated macrophages and enhances anti-PD-1 efficacy in gastric cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Xiao-Bo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0019-885X","authenticated-orcid":false,"given":"Chang-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-4043","authenticated-orcid":false,"given":"Qi-Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-867X","authenticated-orcid":false,"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"8622_CR1","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350\u20135.","journal-title":"Science"},{"key":"8622_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321\u201330.","journal-title":"Nature"},{"key":"8622_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30:660\u20139.","journal-title":"Cell Res"},{"key":"8622_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3593","volume":"362","author":"R Cristescu","year":"2018","unstructured":"Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade\u2013based immunotherapy. Science. 2018;362:eaar3593.","journal-title":"Science"},{"key":"8622_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449\u201356.","journal-title":"Nat Med"},{"key":"8622_CR6","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","volume":"6","author":"K Shitara","year":"2020","unstructured":"Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW, et al. Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial. JAMA Oncol. 2020;6:1571\u201380.","journal-title":"JAMA Oncol"},{"key":"8622_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27\u201340.","journal-title":"Lancet"},{"key":"8622_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NCT, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"8622_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.125","volume":"3","author":"D Wang","year":"2024","unstructured":"Wang D, Zhang J, Wang J, Cai Z, Jin S, Chen G. Identification of collagen subtypes of gastric cancer for distinguishing patient prognosis and therapeutic response. Cancer Innov. 2024;3:e125.","journal-title":"Cancer Innov"},{"key":"8622_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41:49\u201361.","journal-title":"Immunity"},{"key":"8622_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21:799\u2013820.","journal-title":"Nat Rev Drug Discov"},{"key":"8622_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"key":"8622_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14\u201320.","journal-title":"Immunity"},{"key":"8622_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19:369\u201382.","journal-title":"Nat Rev Immunol"},{"key":"8622_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41568-021-00411-8","volume":"22","author":"SJ Vervoort","year":"2022","unstructured":"Vervoort SJ, Devlin JR, Kwiatkowski N, Teng M, Gray NS, Johnstone RW. Targeting transcription cycles in cancer. Nat Rev Cancer. 2022;22:5\u201324.","journal-title":"Nat Rev Cancer"},{"key":"8622_CR16","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/onc.2015.318","volume":"35","author":"A Sveen","year":"2016","unstructured":"Sveen A, Kilpinen S, Ruusulehto A, Lothe RA, Skotheim RI. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene. 2016;35:2413\u201327.","journal-title":"Oncogene"},{"key":"8622_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrm.2017.27","volume":"18","author":"FE Baralle","year":"2017","unstructured":"Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017;18:437\u201351.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8622_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11427-019-1605-0","volume":"63","author":"Y Wang","year":"2020","unstructured":"Wang Y, Bao Y, Zhang S, Wang Z. Splicing dysregulation in cancer: from mechanistic understanding to a new class of therapeutic targets. Sci China Life Sci. 2020;63:469\u201384.","journal-title":"Sci China Life Sci"},{"key":"8622_CR19","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nm.4165","volume":"22","author":"SC Lee","year":"2016","unstructured":"Lee SC, Abdel-Wahab O. Therapeutic targeting of splicing in cancer. Nat Med. 2016;22:976\u201386.","journal-title":"Nat Med"},{"key":"8622_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh7688","volume":"384","author":"A Patowary","year":"2024","unstructured":"Patowary A, Zhang P, Jops C, Vuong CK, Ge X, Hou K, et al. Developmental isoform diversity in the human neocortex informs neuropsychiatric risk mechanisms. Science. 2024;384:eadh7688.","journal-title":"Science"},{"key":"8622_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrc.2016.51","volume":"16","author":"H Dvinge","year":"2016","unstructured":"Dvinge H, Kim E, Abdel-Wahab O, Bradley RK. RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer. 2016;16:413\u201330.","journal-title":"Nat Rev Cancer"},{"key":"8622_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s11658-024-00594-6","volume":"29","author":"M Bei","year":"2024","unstructured":"Bei M, Xu J. SR proteins in cancer: function, regulation, and small inhibitor. Cell Mol Biol Lett. 2024;29:78.","journal-title":"Cell Mol Biol Lett"},{"key":"8622_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1763","volume":"14","author":"K Kumar","year":"2023","unstructured":"Kumar K, Sinha SK, Maity U, Kirti PB, Kumar KRR. Insights into established and emerging roles of SR protein family in plants and animals. Wiley Interdiscip Rev RNA. 2023;14:e1763.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"8622_CR24","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41388-017-0119-6","volume":"37","author":"F Liu","year":"2018","unstructured":"Liu F, Dai M, Xu Q, Zhu X, Zhou Y, Jiang S, et al. SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-\u03baB-CD47 axis. Oncogene. 2018;37:2394\u2013409.","journal-title":"Oncogene"},{"key":"8622_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cac2.12607","volume":"44","author":"J Cai","year":"2024","unstructured":"Cai J, Song L, Zhang F, Wu S, Zhu G, Zhang P, et al. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer Commun. 2024;44:1231\u201360.","journal-title":"Cancer Commun"},{"key":"8622_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"8622_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1349-7006.1998.tb00535.x","volume":"89","author":"M Tatematsu","year":"1998","unstructured":"Tatematsu M, Yamamoto M, Shimizu N, Yoshikawa A, Fukami H, Kaminishi M, et al. Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N\u2019-nitro-N-nitrosoguanidine in drinking water. Jpn J Cancer Res. 1998;89:97\u2013104.","journal-title":"Jpn J Cancer Res"},{"key":"8622_CR28","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1349-7006.1992.tb01999.x","volume":"83","author":"M Tatematsu","year":"1992","unstructured":"Tatematsu M, Ogawa K, Hoshiya T, Shichino Y, Kato T, Imaida K, et al. Induction of adenocarcinomas in the glandular stomach of BALB\/c mice treated with N-Methyl-N-nitrosourea. Jpn J Cancer Res. 1992;83:915\u20138.","journal-title":"Jpn J Cancer Res"},{"key":"8622_CR29","first-page":"2067","volume":"58","author":"A Sugiyama","year":"1998","unstructured":"Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res. 1998;58:2067\u20139.","journal-title":"Cancer Res"},{"key":"8622_CR30","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1136\/gutjnl-2023-331111","volume":"73","author":"XB Huang","year":"2024","unstructured":"Huang XB, Huang Q, Jiang MC, Zhong Q, Zheng HL, Wang JB, et al. KLHL21 suppresses gastric tumourigenesis via maintaining STAT3 signalling equilibrium in stomach homoeostasis. Gut. 2024;73:1785\u201398.","journal-title":"Gut"},{"key":"8622_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.gastro.2020.09.016","volume":"160","author":"ZF Miao","year":"2021","unstructured":"Miao ZF, Sun JX, Adkins-Threats M, Pang MJ, Zhao JH, Wang X, et al. DDIT4 licenses only healthy cells to proliferate during injury-induced metaplasia. Gastroenterology. 2021;160:260\u201371.e10.","journal-title":"Gastroenterology"},{"key":"8622_CR32","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1093\/nar\/gkw1223","volume":"45","author":"L Shkreta","year":"2017","unstructured":"Shkreta L, Blanchette M, Toutant J, Wilhelm E, Bell B, Story BA, et al. Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication. Nucleic Acids Res. 2017;45:4051\u201367.","journal-title":"Nucleic Acids Res"},{"key":"8622_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301977","volume":"10","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Wang HG, Yang JH, Tu RH, Li AY, Zeng GR, et al. Loss of ATOH1 in pit cell drives stemness and progression of gastric adenocarcinoma by activating AKT\/mTOR signaling through GAS1. Adv Sci. 2023;10:e2301977.","journal-title":"Adv Sci"},{"key":"8622_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"B-Z Qian","year":"2010","unstructured":"Qian B-Z, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39\u201351.","journal-title":"Cell"},{"key":"8622_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li X, Yao W, Yuan Y, Chen P, Li B, Li J, et al. Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. 2017;66:157\u201367.","journal-title":"Gut"},{"key":"8622_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115318","volume":"209","author":"S Pozzi","year":"2024","unstructured":"Pozzi S, Satchi-Fainaro R. The role of CCL2\/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine. Adv Drug Deliv Rev. 2024;209:115318.","journal-title":"Adv Drug Deliv Rev"},{"key":"8622_CR37","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1053\/j.gastro.2020.01.046","volume":"158","author":"M Hata","year":"2020","unstructured":"Hata M, Kinoshita H, Hayakawa Y, Konishi M, Tsuboi M, Oya Y, et al. GPR30-expressing gastric chief cells do not dedifferentiate but are eliminated via PDK-dependent cell competition during development of metaplasia. Gastroenterology. 2020;158:1650\u201366.e15.","journal-title":"Gastroenterology"},{"key":"8622_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jcmgh.2017.02.009","volume":"4","author":"Y Hayakawa","year":"2017","unstructured":"Hayakawa Y, Fox JG, Wang TC. Isthmus stem cells are the origins of metaplasia in the gastric corpus. Cell Mol Gastroenterol Hepatol. 2017;4:89\u201394.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"8622_CR39","doi-asserted-by":"publisher","first-page":"641","DOI":"10.14309\/ajg.0000000000000540","volume":"115","author":"SC Shah","year":"2020","unstructured":"Shah SC, Gawron AJ, Li D. Surveillance of gastric intestinal metaplasia. Off J Am Coll Gastroenterol. 2020;115:641\u20134.","journal-title":"Off J Am Coll Gastroenterol"},{"key":"8622_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/path.4735","volume":"239","author":"T Shimizu","year":"2016","unstructured":"Shimizu T, Choi E, Petersen CP, Noto JM, Romero-Gallo J, Piazuelo MB, et al. Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori. J Pathol. 2016;239:399\u2013410.","journal-title":"J Pathol"},{"key":"8622_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-025-02182-2","volume":"23","author":"X Pan","year":"2025","unstructured":"Pan X, Fang Y, Liu X, Guo X, Shen HB. RBPsuite 2.0: an updated RNA-protein binding site prediction suite with high coverage on species and proteins based on deep learning. BMC Biol. 2025;23:74.","journal-title":"BMC Biol"},{"key":"8622_CR42","doi-asserted-by":"publisher","first-page":"9898","DOI":"10.1021\/acs.jafc.2c03629","volume":"70","author":"X Wang","year":"2022","unstructured":"Wang X, Xu J, Zeng H, Han Z. Enhancement of BCAT2-mediated valine catabolism stimulates \u03b2-casein synthesis via the AMPK-mTOR signaling axis in bovine mammary epithelial cells. J Agric Food Chem. 2022;70:9898\u2013907.","journal-title":"J Agric Food Chem"},{"key":"8622_CR43","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14299","volume":"7","author":"ZN Dhanani","year":"2019","unstructured":"Dhanani ZN, Mann G, Adegoke OAJ. Depletion of branched-chain aminotransferase 2 (BCAT2) enzyme impairs myoblast survival and myotube formation. Physiol Rep. 2019;7:e14299.","journal-title":"Physiol Rep"},{"key":"8622_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541\u201350.","journal-title":"Nat Med"},{"key":"8622_CR45","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887\u2013904.","journal-title":"Nat Rev Drug Discov"},{"key":"8622_CR46","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41568-024-00750-2","volume":"24","author":"O Anczukow","year":"2024","unstructured":"Anczukow O, Allain FH, Angarola BL, Black DL, Brooks AN, Cheng C, et al. Steering research on mRNA splicing in cancer towards clinical translation. Nat Rev Cancer. 2024;24:887\u2013905.","journal-title":"Nat Rev Cancer"},{"key":"8622_CR47","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00011-024-01887-4","volume":"73","author":"J Wang","year":"2024","unstructured":"Wang J, Yan L, Wang X, Jia R, Guo J. Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3. Inflamm Res. 2024;73:1123\u201335.","journal-title":"Inflamm Res"},{"key":"8622_CR48","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1158\/0008-5472.CAN-23-3106","volume":"84","author":"J Weng","year":"2024","unstructured":"Weng J, Wang Z, Hu Z, Xu W, Sun JL, Wang F, et al. Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy. Cancer Res. 2024;84:1817\u201333.","journal-title":"Cancer Res"},{"key":"8622_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166941","volume":"1870","author":"ZR Kang","year":"2024","unstructured":"Kang ZR, Jiang S, Han JX, Gao Y, Xie Y, Chen J, et al. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochim Biophys Acta Mol Basis Dis. 2024;1870:166941.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"8622_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1053\/j.gastro.2020.03.018","volume":"159","author":"Y Ma","year":"2020","unstructured":"Ma Y, Li J, Wang H, Chiu Y, Kingsley CV, Fry D, et al. Combination of PD-1 inhibitor and OX40 agonist induces tumor rejection and immune memory in mouse models of pancreatic cancer. Gastroenterology. 2020;159:306\u201319.e12.","journal-title":"Gastroenterology"},{"key":"8622_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122392","volume":"338","author":"W An","year":"2024","unstructured":"An W, Yang Q, Xi Y, Pan H, Huang H, Chen Q, et al. Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma. Life Sci. 2024;338:122392.","journal-title":"Life Sci"},{"key":"8622_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111376","volume":"127","author":"X Luo","year":"2024","unstructured":"Luo X, Zhang Z, Li S, Wang Y, Sun M, Hu D, et al. SRSF10 facilitates HCC growth and metastasis by suppressing CD8(+)T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy. Int Immunopharmacol. 2024;127:111376.","journal-title":"Int Immunopharmacol"},{"key":"8622_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2015","unstructured":"Li X, Yao W, Yuan Y, Chen P, Li B, Li J, et al. Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. 2015;66:157\u201367.","journal-title":"Gut"},{"key":"8622_CR54","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1053\/j.gastro.2023.02.005","volume":"164","author":"C Zhou","year":"2023","unstructured":"Zhou C, Weng J, Liu C, Liu S, Hu Z, Xie X, et al. Disruption of SLFN11 deficiency\u2013induced CCL2 signaling and macrophage M2 polarization potentiates anti\u2013PD-1 therapy efficacy in hepatocellular carcinoma. Gastroenterology. 2023;164:1261\u201378.","journal-title":"Gastroenterology"},{"key":"8622_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00425-023-04132-0","volume":"257","author":"ZC Jia","year":"2023","unstructured":"Jia ZC, Das D, Zhang Y, Fernie AR, Liu YG, Chen M, et al. Plant serine\/arginine-rich proteins: versatile players in RNA processing. Planta. 2023;257:109.","journal-title":"Planta"},{"key":"8622_CR56","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1104\/pp.111.189019","volume":"158","author":"S Califice","year":"2012","unstructured":"Califice S, Baurain D, Hanikenne M, Motte P. A single ancient origin for prototypical serine\/arginine-rich splicing factors. Plant Physiol. 2012;158:546\u201360.","journal-title":"Plant Physiol"},{"key":"8622_CR57","first-page":"663","volume":"1","author":"XD Fu","year":"1995","unstructured":"Fu XD. The superfamily of arginine\/serine-rich splicing factors. Rna. 1995;1:663\u201380.","journal-title":"Rna"},{"key":"8622_CR58","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/biom15111624","volume":"15","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Liu X, Fu J, Wu Y, Yu S, Yao K. Alternative splicing dysregulation in retinitis pigmentosa: pathogenic mechanisms and therapeutic opportunities. Biomolecules. 2025;15:1624.","journal-title":"Biomolecules"},{"key":"8622_CR59","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0960-9822(03)00328-2","volume":"13","author":"C-K Lau","year":"2003","unstructured":"Lau C-K, Diem MD, Dreyfuss G, Van Duyne GD. Structure of the Y14-Magoh core of the exon junction complex. Curr Biol. 2003;13:933\u201341.","journal-title":"Curr Biol"},{"key":"8622_CR60","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1158\/1541-7786.MCR-14-0131","volume":"12","author":"S Das","year":"2014","unstructured":"Das S, Krainer AR. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol Cancer Res. 2014;12:1195\u2013204.","journal-title":"Mol Cancer Res"},{"key":"8622_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley RK, Anczuk\u00f3w O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23:135\u201355.","journal-title":"Nat Rev Cancer"},{"key":"8622_CR62","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1261\/rna.078879.121","volume":"27","author":"L Shkreta","year":"2021","unstructured":"Shkreta L, Delannoy A, Salvetti A, Chabot B. SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication. Rna. 2021;27:1302\u201317.","journal-title":"Rna"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08622-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:03:02Z","timestamp":1780617782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08622-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8622"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08622-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was reviewed and approved by the Ethics Committee of Fujian Medical University Union Hospital (Ethics Approval number: 2021KJT036). All procedures involving human participants were performed in accordance with the Declaration of Helsinki and the relevant guidelines and regulations. Written informed consent was obtained from all patients whose tissue samples were included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"536"}}